Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Title: Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer
Authors: Owen, Dwight H.Aff1, Aff2, IDs1063702501591y_cor1; Wu, RuohanAff1; Wei, LaiAff3; Dikov, MikhailAff1; Suman, ShankarAff1, Aff8; Su, Po-LanAff1, Aff4; Amann, JosephAff1; Guan, ShuxiaoAff1; Spakowicz, DanielAff1, Aff2; Schweitzer, CatherineAff5; Pilcher, CarlyAff5; Smith, Michael B.Aff6; Ferguson, SarahAff5; Palomino, Julio CastroAff7; Pérez, Santiago FigueroaAff7; Bertino, Erin M.Aff1; Shields, Peter G.Aff1, Aff2; He, KaiAff1, Aff2; Presley, Carolyn J.Aff1; Otterson, Gregory A.Aff1; Carson, William E.Aff1, Aff2; Carbone, David P.Aff1, Aff2
Source: Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 43(6):1211-1221
Database: Springer Nature Journals